摘要
Introduction of the phenyl piperidinone and phenyl pyridinone P4 moieties in the anthranilamide scaffold led to potent, selective, and orally bioavailable inhibitors of factor Xa. Anthranilamide rong>28rong> displayed comparable efficacy to apixaban in the rabbit arteriovenous-shunt (AV) thrombosis model.